isatuximab,lenalidomide,carfilzomib,dexamethasone
amgen,sanofi
['concept trial', 'krd', 'omg', 'melphalan', 'gmmg-concept']
#ash2022 katja weisel from university cancer centre hamburg presents an interim from the phase ii concept trial (nct03104842) exploring the quadruplet isatuximab plus krd in high risk ndmm in induction/consolidation, with high-dose melphalan patients undergoing transplant 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma